Journal article · 2024 · Open access

Fusobacterium nucleatum facilitates anti-PD-1 therapy in microsatellite stable colorectal cancer

Xueliang Wang, Yi Fang, Wei Liang, Chi Chun Wong, Huanlong Qin, Yaohui Gao, Meinong Liang, Lei Song, Yongxin Zhang, Miao Fan, Chuanfa Liu, Harry Cheuk-Hay Lau and 12 more

Cancer Cell, 42(10), 1729–1746.e8 · Published 19 September 2024 · DOI 10.1016/j.ccell.2024.08.019

Open full textCite this paper

In brief

“Fusobacterium nucleatum facilitates anti-PD-1 therapy in microsatellite stable colorectal cancer” is a 2024 journal article by Xueliang Wang and 23 co-authors, published in Cancer Cell. OpenAlex counts 295 citations as of 22 November 2026, which puts it in the top 4% of works published in 2024 by citations. It is open access under a CC BY licence: the full text is free to read at Cancer Cell.

Citations
295
Most cited in
2026 (178)
Field-weighted impact
42.08
References
49
Authors
24

Abstract

Microsatellite stable (MSS) colorectal cancers (CRCs) are often resistant to anti-programmed death-1 (PD-1) therapy. Here, we show that a CRC pathogen, Fusobacterium nucleatum ( Fn ), paradoxically sensitizes MSS CRC to anti-PD-1. Fecal microbiota transplantation (FMT) from patients with Fn -high MSS CRC to germ-free mice bearing MSS CRC confers sensitivity to anti-PD-1 compared to FMT from Fn -low counterparts. Single Fn administration also potentiates anti-PD-1 efficacy in murine allografts and CD34 + -humanized mice bearing MSS CRC. Mechanistically, we demonstrate that intratumoral Fn generates abundant butyric acid, which inhibits histone deacetylase (HDAC) 3/8 in CD8 + T cells, inducing Tbx21 promoter H3K27 acetylation and expression. TBX21 transcriptionally represses PD-1, alleviating CD8 + T cell exhaustion and promoting effector function. Supporting this notion, knockout of a butyric acid-producing gene in Fn abolishes its anti-PD-1 boosting effect. In patients with MSS CRC, high intratumoral Fn predicts favorable response to anti-PD-1 therapy, indicating Fn as a potential biomarker of immunotherapy response in MSS CRC.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Wang, X., Fang, Y., Liang, W., Wong, C. C., Qin, H., Gao, Y., Liang, M., Song, L., Zhang, Y., Fan, M., Liu, C., Lau, H. C.-H., Xu, L., Li, X., Wu, S., Wang, J., Wang, N., Yang, T., Mo, M., . . . Yu, J. Q. (2024). Fusobacterium nucleatum facilitates anti-PD-1 therapy in microsatellite stable colorectal cancer. Cancer Cell, 42(10), 1729–1746.e8. https://doi.org/10.1016/j.ccell.2024.08.019

MLA 9

Wang, Xueliang, et al. “Fusobacterium nucleatum facilitates anti-PD-1 therapy in microsatellite stable colorectal cancer.” Cancer Cell, vol. 42, no. 10, 2024, pp. 1729–1746.e8. https://doi.org/10.1016/j.ccell.2024.08.019.

Chicago

Wang, Xueliang, Yi Fang, Wei Liang, Chi Chun Wong, Huanlong Qin, Yaohui Gao, Meinong Liang, et al. 2024. “Fusobacterium nucleatum facilitates anti-PD-1 therapy in microsatellite stable colorectal cancer.” Cancer Cell 42 (10): 1729–1746.e8. https://doi.org/10.1016/j.ccell.2024.08.019.

Harvard

Wang, X. et al. (2024) ‘Fusobacterium nucleatum facilitates anti-PD-1 therapy in microsatellite stable colorectal cancer’, Cancer Cell, 42(10), pp. 1729–1746.e8. doi:10.1016/j.ccell.2024.08.019.

IEEE

X. Wang et al., “Fusobacterium nucleatum facilitates anti-PD-1 therapy in microsatellite stable colorectal cancer,” Cancer Cell, vol. 42, no. 10, pp. 1729–1746.e8, 2024, doi: 10.1016/j.ccell.2024.08.019.

BibTeX

@article{wang2024fusobacterium,
  title     = {{Fusobacterium nucleatum facilitates anti-PD-1 therapy in microsatellite stable colorectal cancer}},
  author    = {Wang, Xueliang and Fang, Yi and Liang, Wei and Wong, Chi Chun and Qin, Huanlong and Gao, Yaohui and Liang, Meinong and Song, Lei and Zhang, Yongxin and Fan, Miao and Liu, Chuanfa and Lau, Harry Cheuk-Hay and Xu, Lixia and Li, Xiaoxing and Wu, Song and Wang, Junlin and Wang, Na and Yang, Tao and Mo, Mengmiao and Zhang, Xiang and Jingyuan, Fang and Liao, Bing and Sung, Joseph J.�Y. and Yu, Jun Qing},
  journal   = {Cancer Cell},
  year      = {2024},
  volume    = {42},
  number    = {10},
  pages     = {1729--1746.e8},
  doi       = {10.1016/j.ccell.2024.08.019},
  url       = {https://doi.org/10.1016/j.ccell.2024.08.019}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202444
2025112112
2026178178

Its field-weighted citation impact is 42.08: it has been cited 42.08 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers

  • Fusobacterium nucleatum
  • microsatellite stable colorectal cancer
  • anti-PD-1 therapy
  • immunotherapy resistance
  • butyrate
  • CD8+ T cell exhaustion
  • TBX21
  • PD-1

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Wang, X., Fang, Y., Liang, W., Wong, C. C., Qin, H., Gao, Y., Liang, M., Song, L., Zhang, Y., Fan, M., Liu, C., Lau, H. C.-H., Xu, L., Li, X., Wu, S., Wang, J., Wang, N., Yang, T., Mo, M., . . . Yu, J. Q. (2024). Fusobacterium nucleatum facilitates anti-PD-1 therapy in microsatellite stable colorectal cancer. Cancer Cell, 42(10), 1729–1746.e8. https://doi.org/10.1016/j.ccell.2024.08.019

How many times has this paper been cited?

295 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Cancer Cell: sign in and open the full text from this page.

Who wrote this paper?

Xueliang Wang, Yi Fang, Wei Liang, Chi Chun Wong, Huanlong Qin, Yaohui Gao, Meinong Liang, Lei Song, Yongxin Zhang, Miao Fan, Chuanfa Liu, Harry Cheuk-Hay Lau and 12 more.

What is the DOI of this paper?

10.1016/j.ccell.2024.08.019, permanently at https://doi.org/10.1016/j.ccell.2024.08.019. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.